Year Founded
2007
Ownership
Private
Therapeutic Areas
RheumatologyDermatology
Stage
Commercial
Modalities
Genomic diagnostics

HairDx General Information

First commercial genetic test for predicting male and female pattern baldness (Androgenetic Alopecia) and Psoriatic Arthritis. Test is CE marked in Europe and FDA Class I registered in US.

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Irvine, California
United States

Drug Pipeline

HairDX Genetic Test
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to HairDx's pipeline data

Book a demo

Key Partnerships

No partnerships listed

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

HairDx Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view HairDx's complete valuation and funding history, request access »